- Home
- NXGL vs PRPH Comparison
NXGL vs PRPH Comparison
Compare NXGL & PRPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NXGL
- PRPH
- Stock Information
- Founded
- NXGL 1997
- PRPH 1989
- Country
- NXGL United States
- PRPH United States
- Employees
- NXGL N/A
- PRPH N/A
- Industry
- NXGL Medical/Dental Instruments
- PRPH Biotechnology: Pharmaceutical Preparations
- Sector
- NXGL Health Care
- PRPH Health Care
- Exchange
- NXGL Nasdaq
- PRPH Nasdaq
- Market Cap
- NXGL 17.8M
- PRPH 14.7M
- IPO Year
- NXGL 2021
- PRPH 1997
- Fundamental
- Price
- NXGL $3.27
- PRPH $0.79
- Analyst Decision
- NXGL
- PRPH Strong Buy
- Analyst Count
- NXGL 0
- PRPH 1
- Target Price
- NXGL N/A
- PRPH $11.00
- AVG Volume (30 Days)
- NXGL 101.5K
- PRPH 277.3K
- Earning Date
- NXGL 11-13-2024
- PRPH 11-13-2024
- Dividend Yield
- NXGL N/A
- PRPH N/A
- EPS Growth
- NXGL N/A
- PRPH N/A
- EPS
- NXGL N/A
- PRPH N/A
- Revenue
- NXGL $6,729,000.00
- PRPH $12,753,000.00
- Revenue This Year
- NXGL $112.89
- PRPH $36.93
- Revenue Next Year
- NXGL $43.11
- PRPH $132.05
- P/E Ratio
- NXGL N/A
- PRPH N/A
- Revenue Growth
- NXGL 90.57
- PRPH N/A
- 52 Week Low
- NXGL $1.71
- PRPH $0.66
- 52 Week High
- NXGL $3.55
- PRPH $7.48
- Technical
- Relative Strength Index (RSI)
- NXGL 57.99
- PRPH 19.28
- Support Level
- NXGL $3.00
- PRPH $0.72
- Resistance Level
- NXGL $3.42
- PRPH $0.83
- Average True Range (ATR)
- NXGL 0.29
- PRPH 0.13
- MACD
- NXGL 0.01
- PRPH -0.05
- Stochastic Oscillator
- NXGL 68.18
- PRPH 7.45
About NXGL NexGel Inc
NexGel Inc manufactures high water content, electron beam cross-linked, aqueous polymer hydrogels, or gels, used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company specializes in custom gels by capitalizing on proprietary manufacturing technologies. The gels and consumer products are manufactured using proprietary and non-proprietary mixing, coating, and cross-linking technologies.
About PRPH ProPhase Labs Inc. (DE)
ProPhase Labs Inc is a diversified company that offers a range of services including diagnostic testing, genomics testing and contract manufacturing. Its operating segments include Diagnostic services and Consumer products. The Diagnostic segment provides COVID-19 diagnostic information services to a broad range of customers in the United States, including health plans, third-party payers and government organizations. The Consumer products segment is engaged in the research, development, manufacture, distribution, marketing and sale of OTC consumer healthcare products and dietary supplements in the United States and also provide personal genomics products and services.